Justin S. Collazo

US Food and Drug Administration Approval Summary: Capivasertib With Fulvestrant for Hormone Receptor–Positive, Human Epidermal Growth Factor Receptor 2–Negative Locally Advanced or Metastatic Breast Cancer With <i>PIK3CA</i> / <i>AKT1</i> / <i>PTEN</i> Alterations

Asma Dilawari, James Buturla, Christy Osgood et al. · Journal of Clinical Oncology · 2024 · 39 citations · Full text

Medicine, Oncology, Pharmacology +17

mRNA expression of MAGE-A3 gene in leukemia cells

Irma Olarte, M.A. Mergold, Mario Gutiérrez et al. · Leukemia Research · 2006 · 31 citations

Medicine, Molecular Biology, Oncology +8

FDA Approval Summary: Pirtobrutinib for Relapsed or Refractory Mantle Cell Lymphoma

Deepti Telaraja, Yvette L. Kasamon, Justin S. Collazo et al. · Clinical Cancer Research · 2023 · 30 citations · Full text

Medicine, Oncology, Pharmacology +16

An economic model of haemophilia in Mexico

Carlos Martı́nez-Murillo, Silvana Maria Quintana, R Ambríz et al. · Haemophilia · 2004 · 18 citations

Pharmacy, Hematology, Pharmacoeconomics +16